Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 330

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change

Luce, Bryan R., Kramer, Judith M., Goodman, Steven N., Connor, Jason T., Tunis, Sean, Whicher, Danielle, Schwartz, J. Sanford · 2009 · Annals of Internal Medicine

Abstract

Medicine and Public Issues4 August 2009Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational ChangeFREEBryan R. Luce, PhD, MBA, Judith M. Kramer, MD, MS, Steven N. Goodman, MD, MHS, PhD, Jason T. Connor, PhD, Sean Tunis, MD, MSc, Danielle Whicher, MHS, and J. Sanford Schwartz, MDBryan R. Luce, PhD, MBAFrom United BioSource Corporation, Bethesda, and Johns Hopkins Schools of Medicine and Public Health and Center for Medical Technology Policy, Baltimore, Maryland; Wharton School and Leonard Davis Institute of Health Economics, University of Pennsylvania, and School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Duke Translational Medicine Institute, Duke University, Durham, North Carolina;and Berry Consultants and University of Central Florida College of Medicine, Orlando, Florida., Judith M. Kramer, MD, MSFrom United BioSource Corporation, Bethesda, and Johns Hopkins Schools of Medicine and Public Health and Center for Medical Technology Policy, Baltimore, Maryland; Wharton School and Leonard Davis Institute of Health Economics, University of Pennsylvania, and School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Duke Translational Medicine Institute, Duke University, Durham, North Carolina;and Berry Consultants and University of Central Florida College of Medicine, Orlando, Florida., Steven N. Goodman, MD, MHS, PhDFrom United BioSource Corporation, Bethesda, and Johns Hopkins Schools of Medicine and Public Health and Center for Medical Technology Policy, Baltimore, Maryland; Wharton School and Leonard Davis Institute of Health Economics, University of Pennsylvania, and School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Duke Translational Medicine Institute, Duke University, Durham, North Carolina;and Berry Consultants and University of Central Florida College of Medicine, Orlando, Florida., Jason T. Connor, PhDFrom United BioSource Corporation, Bethesda, and Johns Hopkins Schools of Medicine and Public Health and Center for Medical Technology Policy, Baltimore, Maryland; Wharton School and Leonard Davis Institute of Health Economics, University of Pennsylvania, and School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Duke Translational Medicine Institute, Duke University, Durham, North Carolina;and Berry Consultants and University of Central Florida College of Medicine, Orlando, Florida., Sean Tunis, MD, MScFrom United BioSource Corporation, Bethesda, and Johns Hopkins Schools of Medicine and Public Health and Center for Medical Technology Policy, Baltimore, Maryland; Wharton School and Leonard Davis Institute of Health Economics, University of Pennsylvania, and School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Duke Translational Medicine Institute, Duke University, Durham, North Carolina;and Berry Consultants and University of Central Florida College of Medicine, Orlando, Florida., Danielle Whicher, MHSFrom United BioSource Corporation, Bethesda, and Johns Hopkins Schools of Medicine and Public Health and Center for Medical Technology Policy, Baltimore, Maryland; Wharton School and Leonard Davis Institute of Health Economics, University of Pennsylvania, and School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Duke Translational Medicine Institute, Duke University, Durham, North Carolina;and Berry Consultants and University of Central Florida College of Medicine, Orlando, Florida., and J. Sanford Schwartz, MDFrom United BioSource Corporation, Bethesda, and Johns Hopkins Schools of Medicine and Public Health and Center for Medical Technology Policy, Baltimore, Maryland; Wharton School and Leonard Davis Institute of Health Economics, University of Pennsylvania, and School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Duke Translational Medicine Institute, Duke University, Durham, North Carolina;and Berry Consultants and University of Central Florida College of Medicine, Orlando, Florida.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-151-3-200908040-00126 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Join the dialogue on health care reform. Comment on the perspectives published in Annals and offer ideas of your own. All thoughtful voices should be heard.While advances in medical science have led to continued improvements in medical care and health outcomes, evidence of the comparative effectiveness of alternative management options remains inadequate for informed medical care and health policy decision making. The result is frequently suboptimal and inefficient care as well as unsustainable costs. To enhance or at least maintain quality of care as health reform and cost containment occurs, better evidence of comparative clinical and cost-effectiveness is required (1). The Amer

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-151-3-200908040-00126

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 330

Metadata

Authors
Luce, B. R., Kramer, J. M., Goodman, S. N., Connor, J. T., Tunis, S., Whicher, D., & Schwartz, J. S.
Venue
Annals of Internal Medicine
Published
2009-08-04
Volume
151
Issue
3
Pages
206-209
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2125855951
Cited by
330
References
16
FWCI
39.63
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change. https://app.cochat.ai/papers/10.7326/0003-4819-151-3-200908040-00126
The paper
Luce, B. R., Kramer, J. M., Goodman, S. N., Connor, J. T., Tunis, S., Whicher, D., & Schwartz, J. S. (2009). Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-151-3-200908040-00126

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.